marketcap
Facebook
Twitter
Telegram
Report an ErrorФармсинтез Financial Statements 2011-2024 | LIFE
Annual Financial Statements Фармсинтез
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2 B | 2.42 B | 1.93 B | 3.31 B | 2.42 B | 1.9 B | 1.75 B | 1.98 B | - | 6.56 B |
Shares |
301 M | 301 M | 301 M | 276 M | 152 M | 152 M | 143 M | 108 M | - | 301 M |
Net Income |
-525 M | -693 M | 59.8 M | -2.52 B | -898 M | -355 M | -205 M | -147 M | - | 14 M |
Revenue |
372 M | 117 M | 282 M | 724 M | 661 M | 331 M | 378 M | 245 M | - | 412 M |
EBITDA |
-22.6 M | -729 M | 36.1 M | -940 M | -510 M | -518 M | -172 M | -156 M | - | 31 M |
Operating Expenses |
201 M | 241 M | -35.5 M | 1.27 B | 985 M | 724 M | 425 M | 292 M | - | 114 M |
General and Administrative Expenses |
24.1 M | 19 M | 31.3 M | 324 M | 355 M | 175 M | 165 M | 157 M | - | - |
All numbers in RUB currency